Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hertenstein

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Leukemia|September 14, 1999
Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantationM Eder, K Battmer, S Kafert, et al.
Deutsche Medizinische Wochenschrift (1946)|October 27, 1997
[Gastrointestinal complications in stem cell transplantation]M Karthaus, P N Meier, M P Manns, et al.
Prenatal Diagnosis|January 27, 2024
Fetal hyperechoic kidneys: Diagnostic considerations and genetic testing strategiesChristine B Hertenstein, Kristen A Miller, Judy A Estroff, et al.
Deutsche Medizinische Wochenschrift (1946)|February 12, 1998
[Liver complications in stem-cell transplantation]M Karthaus, P N Meier, M P Manns, et al.
Transplantation Proceedings|December 1, 1994
Treatment of steroid-resistant acute graft-vs-host disease after allogeneic marrow transplantation with anti-interleukin-2 receptor antibody (BT563)B Hertenstein, M Stefanic, M Sandherr, et al.
Blood|February 1, 1997
Transient increase of leukocytes after transplantation of expanded and nonexpanded allogeneic CD34+ blood cells is of host originL Arseniev, H Link, G Hübner, et al.
Bone Marrow Transplantation|November 1, 1990
Graft failure after T cell-depleted bone marrow transplantation: clinical and immunological characteristics and response to immunosuppressive therapyD Bunjes, M Wiesneth, B Hertenstein, et al.
Leukemia|September 14, 2007
A new case with rare e6a2 BCR-ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatmentS Schnittger, U Bacher, W Kern, et al.
Annals of Hematology|March 31, 2000
Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberrationP Schöffski, A Ganser, U Pascheberg, et al.
Journal of Psychosomatic Research|June 12, 2001
Associations between coping and survival time of adult leukemia patients receiving allogeneic bone marrow transplantation: results of a prospective studyV Tschuschke, B Hertenstein, R Arnold, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Leukemia|September 14, 1999
Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantationM Eder, K Battmer, S Kafert, et al.
Deutsche Medizinische Wochenschrift (1946)|October 27, 1997
[Gastrointestinal complications in stem cell transplantation]M Karthaus, P N Meier, M P Manns, et al.
Prenatal Diagnosis|January 27, 2024
Fetal hyperechoic kidneys: Diagnostic considerations and genetic testing strategiesChristine B Hertenstein, Kristen A Miller, Judy A Estroff, et al.
Deutsche Medizinische Wochenschrift (1946)|February 12, 1998
[Liver complications in stem-cell transplantation]M Karthaus, P N Meier, M P Manns, et al.
Transplantation Proceedings|December 1, 1994
Treatment of steroid-resistant acute graft-vs-host disease after allogeneic marrow transplantation with anti-interleukin-2 receptor antibody (BT563)B Hertenstein, M Stefanic, M Sandherr, et al.
Blood|February 1, 1997
Transient increase of leukocytes after transplantation of expanded and nonexpanded allogeneic CD34+ blood cells is of host originL Arseniev, H Link, G Hübner, et al.
Bone Marrow Transplantation|November 1, 1990
Graft failure after T cell-depleted bone marrow transplantation: clinical and immunological characteristics and response to immunosuppressive therapyD Bunjes, M Wiesneth, B Hertenstein, et al.
Leukemia|September 14, 2007
A new case with rare e6a2 BCR-ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatmentS Schnittger, U Bacher, W Kern, et al.
Annals of Hematology|March 31, 2000
Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberrationP Schöffski, A Ganser, U Pascheberg, et al.
Journal of Psychosomatic Research|June 12, 2001
Associations between coping and survival time of adult leukemia patients receiving allogeneic bone marrow transplantation: results of a prospective studyV Tschuschke, B Hertenstein, R Arnold, et al.
Pageof 11